Summary
Pfizer Inc. filed this Form 8-K on April 28, 2015, primarily to furnish a press release announcing its financial results for the first quarter of 2015. While the 8-K itself contains minimal detail, it directs investors to the attached press release (Exhibit 99) for comprehensive information regarding the company's performance during the period. Investors should review this press release for specific revenue, earnings, and operational updates from Pfizer.
Key Highlights
- 1Pfizer announced its first-quarter 2015 financial results on April 28, 2015.
- 2The 8-K filing serves as a mechanism to incorporate the press release containing these results.
- 3The press release, filed as Exhibit 99, is the primary source of detailed financial and operational information.
- 4Investors are directed to the press release for specific performance metrics.
- 5The filing confirms that the press release is considered 'filed' under the Securities Exchange Act of 1934.